Anomalous expression of TGFα or EGFR by cancer cells is associated with an aggressive phenotype and poor prognosis [11], also because the activation of EGFR signaling results in up-regulation of pro-angiogenic factors such as VEGF. Here, EGFR is linked to cancer.